Facilitated by MDIC’s Health Economics and Patient Value (HEPV) program, the Commercial Payer Council serves as a neutral platform for critical conversations, drawing together visionaries from various sectors including integrated healthcare delivery networks, payers, device companies, health plans, health technology assessment organizations, law firms and consultants in health policy, market access, and reimbursement.
Get Involved
For further information regarding the MDIC Commercial Payer Council and how to get involved, interested parties are encouraged to reach out to Harry Kotlarz, Vice President of HEPV, via email at hkotlarz@mdic.org.
Senior medical officers, reimbursement strategists, and industry experts examine the opportunities and challenges that GLP-1 drugs pose for payers, medical device companies, and patients.